NASDAQ:PODD - Insulet Stock Price, Forecast & News

Insulet's stock was trading at $172.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PODD stock has decreased by 7.5% and is now trading at $159.17. View which stocks have been mosted impacted by Coronavirus.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Insulet in the last year. There are currently 1 sell rating, 8 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Insulet.

Insulet is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Insulet.

Insulet Co. (NASDAQ:PODD) announced its quarterly earnings results on Tuesday, February, 25th. The medical instruments supplier reported $0.08 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.09 by $0.01. The medical instruments supplier earned $209.40 million during the quarter, compared to analyst estimates of $197.79 million. Insulet had a net margin of 1.58% and a return on equity of 9.56%. View Insulet's earnings history.

Insulet issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, February, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $841.548-871.076 million, compared to the consensus revenue estimate of $879.83 million.

19 Wall Street analysts have issued 12 month price objectives for Insulet's shares. Their forecasts range from $100.00 to $215.00. On average, they anticipate Insulet's stock price to reach $171.50 in the next year. This suggests a possible upside of 7.7% from the stock's current price. View analysts' price targets for Insulet.

Media headlines about PODD stock have been trending very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Insulet earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutInsulet.

Some companies that are related to Insulet include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Masimo (MASI) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Insulet investors own include Alibaba Group (BABA), Netflix (NFLX), NVIDIA (NVDA), DexCom (DXCM), salesforce.com (CRM), Roku (ROKU), Tandem Diabetes Care (TNDM), Splunk (SPLK), Veeva Systems (VEEV) and Adobe (ADBE).

Insulet trades on the NASDAQ under the ticker symbol "PODD."

Shares of PODD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PODD stock can currently be purchased for approximately $159.17.

Insulet has a market capitalization of $10.01 billion and generates $738.20 million in revenue each year. The medical instruments supplier earns $11.60 million in net income (profit) each year or $0.19 on an earnings per share basis. Insulet employs 1,350 workers across the globe. View additional information about Insulet.

The official website for Insulet is http://www.insulet.com/.

Insulet's mailing address is 100 NAGOG PARK, ACTON MA, 01720. The medical instruments supplier can be reached via phone at 978-600-7000 or via email at [email protected]